Universal Biosensors Logo

Skip to content

X

  • Home
  • About
    • About Us
    • Board of Directors
    • Senior Management
    • Scientific Advisory Panel
    • Company History
    • Join Our Team
  • Technology
    • Technology Overview
    • Manufacturing
  • Products
    • Xprecia™
      • Products
      • Resources
      • Distributors
      • Distributor Portal
    • Sentia™
      • Products
      • – Sentia™ Analyzer
      • – Sentia™ Free SO₂ Test Strips
      • – Sentia™ Malic Acid Test Strips
      • – Sentia™ Glucose and Fructose Test Strips
      • – Sentia™ Acetic Acid Test Strips
      • – Sentia™ Meter Case
      • Distributors
      • How to buy
      • Resources
      • Videos
      • Sentia™ FAQs
      • Pulse Login
    • Laboratory Services
      • Our Team
      • Services
      • Case Studies
      • Quality Mission
      • News
      • Contact Us
    • PETRACKR®
      • Products
      • – PETRACKR® Blood Glucose Monitoring System
      • – PETRACKR® Blood Glucose Test Strips
      • – PETRACKR® App
      • – PETRACKR® Mid Control Solution
      • – PETRACKR® Lancet Device
      • – PETRACKR® Lancets
      • Resources
      • Distributors
      • How to order PETRACKR®
    • Product Pipeline
  • Investor Centre
    • Annual Reports
    • ASX Announcements
    • ASX Share Price
    • SEC Filings
    • Corporate Directory
    • Corporate Governance
    • Top 20 Holdings
    • Analyst Coverage
  • Support
    • Contact Us
    • UBI Pulse Knowledge Base and FAQs
    • UBI Pulse Customer Portal Login

UBI Signs new technology licensing deal to commercialise SARS-CoV-2 N- Protein test

Posted in News on December 24, 2021.

UBI Signs new technology licensing deal to commercialise SARS-CoV-2 N- Protein test PDF

© 2024 Universal Biosensors